Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06189976

Rapid Atrial Pacing After TAVI as a Predictor of Permanent Pacemaker Implantation

Led by National and Kapodistrian University of Athens · Updated on 2024-12-12

400

Participants Needed

2

Research Sites

35 weeks

Total Duration

On this page

Sponsors

N

National and Kapodistrian University of Athens

Lead Sponsor

C

Centre Hospitalier Universitaire Saint Pierre

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying patients undergoing Transcatheter Aortic Valve Implantation (TAVI) to address the challenge of needing permanent pacemaker implantation (PPI) after TAVI. This trial investigates the use of rapid atrial pacing (RAP), a simple test using a temporary pacemaker lead, as a way to predict which patients might require PPI. The study aims to clarify the value of RAP in improving decision-making post-TAVI given the current variability in PPI rates and the impact of PPI on long-term health outcomes. The study involves placing a temporary pacemaker lead in the right atrium before and after the TAVI procedure in patients who are stable and not dependent on a pacemaker. RAP is performed by increasing the pacing rate until a certain type of atrioventricular block is observed or a maximum rate of 150 beats per minute is reached. The test is done twice, before and after the valve implantation, to record the heart's response to pacing. Participants will be closely monitored during the procedure and follow-up visits. Data collected include electrocardiograms and RAP test results, with ongoing recording of any adverse events. The main outcome measured is the rate of permanent pacemaker implantation within 30 days after TAVI, along with mortality and PPI rates tracked at 6 and 12 months. Investigators will maintain detailed records throughout the trial to ensure safety and accurate data reporting.

CONDITIONS

Brief Title

Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years old or older
  • Patient understands the trial purpose, risks, and benefits and agrees to follow-up
  • Patient has signed informed consent
  • Patients undergoing TAVI for severe aortic stenosis
  • Patient is in normal sinus rhythm
  • Patients planned for TAVI with temporary pacemaker electrode placement
Not Eligible

You will not qualify if you...

  • Active infection, including endocarditis
  • Existing permanent pacemaker or implantable cardioverter/defibrillator
  • Persistent second or third degree atrioventricular block after TAVI
  • Heart rhythm other than sinus after TAVI
  • Second or third degree atrioventricular block on pre-TAVI ECG
  • Participation in another interfering study
  • Unable to comply with follow-up requirements
  • Pregnant or breastfeeding females or intending pregnancy during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Procedure day

Participants undergo Transcatheter Aortic Valve Implantation (TAVI) with temporary pacemaker electrode placement. Rapid atrial pacing (RAP) tests are performed before and after the TAVI procedure to assess atrioventricular conduction.

1 visit (in-person) on the day of TAVI

Long-term Monitoring

Duration - 12 months

Participants are monitored for permanent pacemaker implantation and mortality outcomes for up to 12 months following the TAVI procedure.

Follow-up visits as per local practice up to 12 months

Trial Site Locations

Total: 2 locations

1

CHU Saint-Pierre

Brussels, Belgium, 1000

Actively Recruiting

2

Hippocration Hospital

Athens, Attica, Greece, 11527

Actively Recruiting

Loading map...

Research Team

L

Leonidas Koliastasis, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

A Clinical and Imaging Registry of Transcatheter Aortic Valv...

Aortic Valve Disease

Actively Recruiting

1 location

Ambulatory Electrocardiographic Monitoring for Detecting Hig...

Aortic Valve Disease

Actively Recruiting

1 location

Aortic Valve Diseases RISk facTOr assessmenT and Prognosis m...

Aortic Valve Disease

Actively Recruiting

7 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Electrophysiology Testing to Stratify Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation.

Sven Knecht, Beat Schaer, Tobias Reichlin...

https://pubmed.ncbi.nlm.nih.gov/32089049

Utility of rapid atrial pacing before and after TAVR with balloon-expandable valve in  predicting permanent pacemaker implantation.

Bryan E-Xin Tan, Anas Hashem, Leela K T Boppana...

https://pubmed.ncbi.nlm.nih.gov/37698294